Tag:
sequencing
Latest Headlines
Latest Headlines
Life Tech accepts Thermo's $13.6B bid
After months of hints and allegations, Thermo Fisher has come out on top in the scrum to acquire Life Technologies, signing a deal to buy the sequencing giant for $13.6 billion.
GE launches cancer assay with eye on companion Dx
GE Healthcare has been steadily building up its diagnostics offerings over the past three years, and now the company is launching a sequencing assay targeting solid tumors in clinical trials.
Report: Life Tech may have found a buyer after all
The hot and cold rumors over a potential Life Technologies sale have swung back toward the former, as Bloomberg 's sources say a team of private equity outfits are exploring an offer for the sequencing giant.
Troubled sequencing pioneer Helicos shelters in bankruptcy court
Delisted and largely dumped by investors after a pair of restructurings failed to cure what ailed it, Cambridge, MA-based Helicos BioSciences ($HLCS) has stepped into bankruptcy court seeking Chapter 11 protection for the genomic sequencing company.
Third Rock's Levin calls for teamwork in personalized medicine
Personalized medicine has the potential to revolutionize biotech and pharma, but only if stakeholders work together, Levin said.
Life Technologies expands manufacturing in Scotland
Life Technologies is lining up its pieces to get more of the genetic sequencing market with a manufacturing plant expansion in Scotland.
PacBio starts shipping Real-Time sequencing machine
This week Pacific Biosciences--the biotech superstar that has raised hundreds of millions in venture capital and launched an IPO --started shipping its PacBio RS system. According to a release, the
Genomics companies finally bear fruit
Daiichi Sankyo paid almost a billion dollars last month to get its hands on Plexxicon's PLX4032, a melanoma drug that turns off a signal that tells cells to divide. Plexxicon discovered the drug
Life Technologies inks $725M deal for Ion Torrent
Arming itself for a looming showdown with Illumina over the booming market for second-generation gene sequencing technologies, Life Technologies struck a deal to buy Ion Torrent for $375 million in
Pioneering personal sequencing projects unveil disease triggers
Taking advantage of lower cost genome sequencing technology, two independent teams of researchers have sequenced the genomes of sick patients to determine the precise genetic trigger to their disease
